US 11,690,609 B2
Devices and methods for the treatment of heart failure
David Stephen Celermajer, Vaucluse (AU)
Assigned to Corvia Medical, Inc., Tewksbury, MA (US)
Filed by Corvia Medical, Inc., Tewksbury, MA (US)
Filed on Apr. 21, 2020, as Appl. No. 16/854,100.
Application 16/854,100 is a continuation of application No. 12/447,617, granted, now 10,624,621, previously published as PCT/AU2007/001704, filed on Nov. 7, 2007.
Claims priority of application No. 2006906202 (AU), filed on Nov. 7, 2006.
Prior Publication US 2020/0245991 A1, Aug. 6, 2020
Int. Cl. A61F 2/24 (2006.01); A61B 17/02 (2006.01); A61B 17/00 (2006.01); A61F 2/06 (2013.01); A61M 27/00 (2006.01)
CPC A61B 17/02 (2013.01) [A61B 17/0057 (2013.01); A61F 2/06 (2013.01); A61F 2/24 (2013.01); A61F 2/2412 (2013.01); A61F 2/2442 (2013.01); A61F 2/2475 (2013.01); A61M 27/002 (2013.01); A61B 2017/00252 (2013.01); A61B 2017/00575 (2013.01); A61B 2017/00592 (2013.01); A61B 2017/00606 (2013.01); A61B 2017/00867 (2013.01); A61B 2017/0237 (2013.01)] 3 Claims
OG exemplary drawing
 
1. A device for treating a heart condition in a patient, the device comprising:
a Nitinol mesh body adapted and configured to self-expand from a radially collapsed configuration to an expanded configuration, the body in its expanded configuration comprising a first flange and a second flange, each of the first and second flanges having an exterior face and an interior face, the body further comprising a central portion extending between the first and second flanges, the interior faces of the first and second flanges defining an annular gap surrounding the central portion, the interior faces of each of the first and second flanges having diameters that gradually increase with distance from the central portion of the body toward their respective exterior faces, the exterior faces of the first and second flanges having diameters that decrease with distance from their respective interior faces,
wherein the body has a centrally located passage having a diameter of about 4-15 mm extending through the first and second flanges and the central portion,
the body being configured to be delivered percutaneously to a patient's heart in the radially collapsed condition in which the exterior faces of the first and second flanges are separated, thereby causing the device to lengthen and reduce in diameter, and to self-expand to the expanded configuration in an opening in a septum of the heart to dispose the first flange in the left atrium, the second flange in the right atrium and the central portion of the body in the opening to permit blood to flow from the left atrium to the right atrium.